DiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest Down 8.6% in November

DiaSorin S.p.A. (OTCMKTS:DSRLF) was the recipient of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 35,100 shares, a decline of 8.6% from the November 15th total of 38,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is presently ∞ days.

Wall Street Analysts Forecast Growth

Separately, UBS Group downgraded DiaSorin from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 26th.

DiaSorin Trading Down 0.3 %

Shares of OTCMKTS:DSRLF opened at $106.85 on Tuesday. DiaSorin has a twelve month low of $105.88 and a twelve month high of $108.79. The company’s 50 day moving average is $104.87 and its 200 day moving average is $102.91.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.